Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

BACKGROUND: The complexity of delivering precision medicine to oncology patients has led to the creation of molecular tumourboards (MTBs) for patient selection and assessment of treatment options. New technologies like the liquid biopsy are augmenting available therapeutic opportunities. This report...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolfo, Christian, Manca, Paolo, Salgado, Roberto, Van Dam, Peter, Dendooven, Amelie, Machado Coelho, Andreia, Ferri Gandia, Jose, Rutten, Annemie, Lybaert, Willem, Vermeij, Joanna, Gevaert, Thomas, Weyn, Christine, Lefebure, Anneke, Metsu, Sofie, Van Laere, Steven, Peeters, Marc, Pauwels, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069914/
https://www.ncbi.nlm.nih.gov/pubmed/30094075
http://dx.doi.org/10.1136/esmoopen-2018-000398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069914/
https://www.ncbi.nlm.nih.gov/pubmed/30094075
http://dx.doi.org/10.1136/esmoopen-2018-000398

Ejemplares similares